Literature DB >> 28091366

Trastuzumab emtansine and cost-based decision making.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28091366     DOI： 10.1016/S0140-6736(17)30006-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  1 in total

Review 1.  Neoadjuvant Treatment with HER2-Targeted Therapies in HER2-Positive Breast Cancer: A Systematic Review and Network Meta-Analysis.

Authors:  Agampodi Danushi M Gunasekara; Thunyarat Anothaisintawee; Sitaporn Youngkong; Nguyen T Ha; Gareth J McKay; John Attia; Ammarin Thakkinstian
Journal:  Cancers (Basel)       Date:  2022-01-21       Impact factor: 6.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.